BPMC
Blueprint Medicines
BPMC
BPMC
Delisted
BPMC was delisted on the 17th of July, 2025.
235 hedge funds and large institutions have $5.28B invested in Blueprint Medicines in 2020 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 82 increasing their positions, 81 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% more repeat investments, than reductions
Existing positions increased: 82 | Existing positions reduced: 81
0% more funds holding
Funds holding: 234 → 235 (+1)
0.2% less ownership
Funds ownership: 103.81% → 103.61% (-0.2%)
Holders
235
Holding in Top 10
8
Calls
$31M
Puts
$21.6M
Top Buyers
| 1 | +$138M | |
| 2 | +$90.5M | |
| 3 | +$52.2M | |
| 4 |
TCM
TimesSquare Capital Management
New York
|
+$30.7M |
| 5 |
N
Natixis
Paris,
France
|
+$30.6M |
Top Sellers
| 1 | -$58M | |
| 2 | -$42.9M | |
| 3 | -$34.9M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$32.9M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$31.9M |